Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 4, 2003

View Archived Issues

PH-027, a novel antimicrobial agent, has potent activity against anaerobic bacteria

NO blocks platelet-leukocyte aggregate formation in acute respiratory distress syndrome

Cathepsin B as a therapeutic target in cancer and arthritis

Duloxetine for painful diabetic neuropathy

Rapid absorption and onset of action for insulin glulisine in dogs and humans

Novel cathepsin K inhibitors in GSK development pipeline

ACAT inhibitors prepared and tested at Takeda

Yamanouchi scientists describe new PARP inhibitors and their use

Shionogi patent describes new antidiabetic agents

Novel group II mGluR antagonists under study at Taisho

Beneficial effects described for inhaled insulin in type 2 diabetes

Potential role for ruboxistaurin in diabetic microvascular complications

Acetyl-CoA carboxylase inhibitors, their preparation and use claimed by Ajinomoto

Neuroprotective effects of AT-1015 in rats with diabetic neuropathy

Mechanism of protective effects of pyridoxamine against diabetic nephropathy

Second approvable letter issued for duloxetine

TLK-286 awarded fast track status for advanced ovarian cancer

Avandia label expanded in Europe

New PPARalpha activator improves insulin sensitivity and lipid profiles in primates

HIM2 effects on glucose production and disposal in nondiabetic subjects

Rifaximin efficacy confirmed in phase III travelers' diarrhea trial

Satraplatin phase III trial cleared to begin

Paxil CR approved for premenstrual dysphoric disorder

BMS returns quinolone antibiotic to Toyama

Bifeprunox to enter phase III development for schizophrenia

FluMist available for 2003-2004 influenza season

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...